Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EMAYX | 16.77 | -0.13 | -0.77% |
| Gabelli Entpr Mergers & Acquisitions Y | |||
| EQTIX | 17.66 | -0.18 | -1.01% |
| Shelton Equity Income Investor | |||
| CGVHX | 23.66 | -0.25 | -1.05% |
| American Funds Global Insight 529-F-3 | |||
| FIDJX | 13.89 | -0.20 | -1.42% |
| Fidelity SAI Sustainable Sector Fund | |||
| USLYX | 79.53 | -1.81 | -2.23% |
| JHancock U.S. Global Leaders Growth R2 | |||
A.I.dvisor tells us that DOSEF and MNPR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and MNPR's prices will move in lockstep.
| Ticker / NAME | Correlation To DOSEF | 1D Price Change % | ||
|---|---|---|---|---|
| DOSEF | 100% | N/A | ||
| MNPR - DOSEF | 24% Poorly correlated | -0.77% | ||
| AKRO - DOSEF | 23% Poorly correlated | -5.61% | ||
| SGMT - DOSEF | 21% Poorly correlated | -8.69% | ||
| ADAG - DOSEF | 21% Poorly correlated | -6.90% | ||
| CLRPF - DOSEF | 12% Poorly correlated | -2.95% | ||
More | ||||